All the above results suggested that the mitochondrial protective effect of IL-37 in cardiomyocytes is related to SIRT1-mediated activation of AMPK followed by increased PGC-1α expression, through which IL-37 possesses anti-cardiac hypertrophy property. The gene discussed is PPARGC1A; the disease is cardiac hypertrophy.